CNE100004ZK3
CNE100004ZK3
NANJING VAZYME BIOTECH CO LTD
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.377.881.285 | 1.377.898.265 | 0.0% |
| Cost of Revenue | 419.662.700 | 414.356.563 | 1.3% |
| Gross Profit | 958.218.585 | 963.541.701 | 0.6% |
| 994.034.560 | 1.019.096.595 | 2.5% | |
| Operating Income | -35.815.975 | -55.554.894 | 35.5% |
| Pretax Income | -37.707.201 | -58.251.326 | 35.3% |
| Net Income Common Stockholders | -16.613.336 | -18.093.810 | 8.2% |
| -- | -- | -- | |
| -- | -- | -- |